Myeloperoxidase as a biomarker for anticipating STEMI in individuals with atrial fibrillation.

13 May 2024 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease / chronic coronary syndromes 1 Revascularisation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by